Business ❯ Corporate Strategy ❯ Mergers and Acquisitions
Investment Opportunities Investor Relations Investor Sentiment Investment Strategies Tech Industry Vertical Integration Financial Performance Private Equity Firms Netflix Mobile Game Studios
The deal gives Lilly a preclinical Tethosome non‑viral DNA delivery platform, a lipid‑nanoparticle approach designed to target potency, tolerability and re‑dosing limits in DNA therapies.